WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
investors@aclaristx.com
HOUSTON, June 24, 2025 /PRNewswire/ -- AllianceHCM, one of the nation's leading privately held providers…
Sartorius launches a premier industry event focused on process intensification (PI) for protein therapeutics and…
Rising Pharmaceutical Innovation, AI Integration, and Point-of-Care Testing Applications Drive 9.8% CAGR Growth Across Healthcare…
BOSTON, June 24, 2025 /PRNewswire/ -- Calibre One, a leading global executive search firm specializing…
FRISCO, Texas, June 24, 2025 /PRNewswire/ -- Careington International Corporation is proud to announce enhanced customer…
While Americans are confident in their ability to handle regular financial obligations, unexpected expenses reveal gaps…